StemCell Institute — Investor Relations & Filings
StemCell Institute Inc. is a private cord blood bank established in 1999. The company specializes in the collection, processing, and long-term cryopreservation of stem cells from umbilical cord blood and umbilical cord tissue. Its services are targeted at expectant parents who wish to store these biological materials for potential future use in regenerative medicine and cell therapies for their child or family members. The company operates a state-of-the-art cell processing center and a large-scale cryopreservation facility. It is the largest private cord blood bank in its domestic market, holding over 99% market share and storing more than 80,000 units. StemCell Institute is the only private bank in its region to have released stored units for clinical applications, including treatments for conditions such as leukemia and cerebral palsy. The company is ISO 9001 certified.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 取締役及び補欠監査役の候補者選任に関するお知らせ | 2026-05-20 | Japanese | |
| ストック・オプション（新株予約権）の発行に関するお知らせ | 2026-05-20 | Japanese | |
| 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-12-01 | Japanese | |
| 確認書 | 2025-11-14 | Japanese | |
| 半期報告書－第27期(2025/04/01－2026/03/31) | 2025-11-14 | Japanese | |
| 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-11-04 | Japanese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 46580522 | 取締役及び補欠監査役の候補者選任に関するお知らせ | 2026-05-20 | Japanese | ||
| 46580518 | ストック・オプション（新株予約権）の発行に関するお知らせ | 2026-05-20 | Japanese | ||
|
2025
13 filings
| |||||
| 8953930 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-12-01 | Japanese | ||
| 8318037 | 確認書 | 2025-11-14 | Japanese | ||
| 8318010 | 半期報告書－第27期(2025/04/01－2026/03/31) | 2025-11-14 | Japanese | ||
| 8070504 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-11-04 | Japanese | ||
| 7943254 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-10-01 | Japanese | ||
| 7856561 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-09-01 | Japanese | ||
| 7859626 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-08-01 | Japanese | ||
| 7242232 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-07-01 | Japanese | ||
| 7248677 | 臨時報告書 | 2025-06-26 | Japanese | ||
| 7253208 | 内部統制報告書－第26期(2024/04/01－2025/03/31) | 2025-06-24 | Japanese | ||
| 7253197 | 確認書 | 2025-06-24 | Japanese | ||
| 7253194 | 有価証券報告書－第26期(2024/04/01－2025/03/31) | 2025-06-24 | Japanese | ||
| 7260727 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-06-02 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Other human health activities n.e.c
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Omada Health, Inc.
A virtual care provider offering digital programs for manag…
|
OMDA | US | Human health and social work ac… |
|
OPKO Health Inc.
An integrated healthcare company in pharmaceuticals and dia…
|
OPK | US | Human health and social work ac… |
|
OPTIMA HEALTH PLC
Provider of tech-enabled occupational health and corporate …
|
OPT | GB | Human health and social work ac… |
|
Option Care Health, Inc.
An independent provider of home and alternate site infusion…
|
OPCH | US | Human health and social work ac… |
|
OverActive Media Corp.
Global esports organization operating pro teams and providi…
|
OAM | CA | Human health and social work ac… |
|
Pacgen Life Science Corporation
Distributes consumer health products and offers advanced mo…
|
PBS | CA | Human health and social work ac… |
|
PANGAEA Oncology
A medical services company specializing in precision oncolo…
|
PANG | ES | Human health and social work ac… |
|
PARADISE.Co.,Ltd.
An integrated resort and hospitality company operating fore…
|
034230 | KR | Human health and social work ac… |
|
Pathway Health Corp.
Specializes in out-of-hospital pain management and mental h…
|
— | CA | Human health and social work ac… |
|
Pennant Group, Inc.
A holding company providing home health, hospice, home care…
|
PNTG | US | Human health and social work ac… |
StemCell Institute via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14298/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14298 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14298 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14298 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14298}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for StemCell Institute (id: 14298)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.